close Icon
  1. Home
  2. Knowledge and Media
  3. Research Articles
  4. Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standar...

Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique.

Bastard M, Molfino L, Mutaquiha C, Galindo MA, Zindoga P, Vaz D, Mahinça I, DuCros P, Rusch B, Telnov A

VIEW FULL ARTICLE

  • Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

  • Published 25 Sep 2020

  • Volume 69

  • ISSUE 10

  • Pagination 1809-1811

  • DOI 10.1093/cid/ciz196

Abstract

Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.